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Abstract The incidence and expression of cardiovascular
diseases differs between the sexes. This is not surprising, as
cardiac physiology differs between men and women. Clinical
and basic science investigations have shown important sex
differences in cardiac structure and function. The pervasive-
ness of sex differences suggests that such differences must be
fundamental, likely operating at a cellular level. Indeed, stud-
ies have shown that isolated ventricular myocytes from female
animals have smaller and slower contractions and underlying
calcium transients compared to males. Recent evidence sug-
gests that this arises from sex differences in components of the
cardiac excitation–contraction coupling pathway, the se-
quence of events linking myocyte depolarization to calcium
release from the sarcoplasmic reticulum and subsequent con-
traction. The concept that sex hormones may regulate intra-
cellular calcium at the level of the cardiomyocyte is important,
as levels of these hormones decline in bothmen and women as
the incidence of cardiovascular disease rises. This review
focuses on the impact of sex on cardiac contraction, in partic-
ular at the cellular level, and highlights specific components of
the excitation–contraction coupling pathway that differ be-
tween the sexes. Understanding sex hormone regulation of
calcium homeostasis in the heart may reveal new avenues for
therapeutic strategies to treat cardiac dysfunction and cardio-
vascular diseases.
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Introduction
Clinical studies have identified striking differences between
men and women in the incidence and expression of many
different cardiovascular diseases. This should not be surpris-
ing; there are also sex differences in the normal structure and
physiology of the heart. Although information is limited,
there is evidence that myocardial electrical and contractile
function differ between the sexes. Studies that have included
both males and females have distinguished important differ-
ences in cardiac contractile function, even at the level of the
individual cardiomyocyte. Additionally, cardiomyocytes
possess receptors for major sex steroid hormones, and these
hormones are thought to regulate myocardial function. This
has led to considerable interest in identifying the cellular
mechanisms responsible for sex differences in myocardial
function. Indeed, recent studies have identified intriguing
differences at several different levels of the excitation–con-
traction (EC) coupling pathway, which is responsible for the
contraction of individual cardiomyocytes.
This review highlights our knowledge of the impact of
sex on cardiac contraction and examines specific compo-
nents of the EC coupling pathway that differ between males
and females. Acute and chronic effects of sex hormones on
components of this pathway are also considered. Current
controversies are discussed, and important questions are
raised for future research. Further understanding of the
cellular mechanisms responsible for sex differences in myo-
cardial function can begin to reveal why varying pathologies
arise in males and females. This could lead to a better
appreciation of the role of sex hormones in the regulation
of cardiac function and to the development of more appro-
priate sex-specific therapies for cardiovascular diseases.
This article is published as part of the Special Issue on “Sex differences
in health and disease: brain and heart connections”.
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Sex differences in cardiac function
Important differences have been described in the incidence
and susceptibility to cardiovascular disease in men and
women [30, 84, 90]. For example, women typically experi-
ence coronary artery disease and myocardial infarction
about 10 years later than men [87]. Hypertrophic and dilated
cardiomyopathies both occur more frequently in men than in
women, whereas Tako-Tsubo cardiomyopathy is seen al-
most exclusively in women [87]. Men also tend to develop
heart failure with impaired systolic function as they age,
while older women have a higher incidence of heart failure
with preserved ejection fraction [87].
These differences in cardiac pathophysiology may origi-
nate, at least in part, from sex differences in the structure and
function of the heart. In humans, echocardiographic studies
have revealed that left ventricular (LV) mass is significantly
smaller in women than in men [31, 32]. Echocardiography has
also shown that females have reduced LV end-diastolic di-
mension [11, 111]. In addition, women have higher resting
heart rates and longer corrected QT intervals than men [52,
125]. Radiographic studies using ventriculography have dem-
onstrated that women possess a higher ejection fraction at rest
thanmen [11]. Even so, men respond to exercise with a greater
increase in ejection fraction than do women [52, 76]. This
decrease in the ability of the female heart to respond to
increased demand has been shown to be independent of sex
differences in myocardial regulation by the sinus node or by
autonomic tone [15]. This raises the question of whether
individual cardiomyocytes from female hearts may have lim-
ited ability to augment contractile function, in particular in
response to stimuli that increase demand.
Studies in animal models have provided additional evi-
dence that cardiac contractile function differs between the
sexes. In a working heart model, female rats have a smaller
ejection fraction and exhibit less fractional shortening in
comparison to age-matched males [95]. Studies in cardiac
muscle strips from rats found similar results, in that
responses were smaller and slower in females in comparison
to males, particularly in conditions of higher demand such
as rapid pacing rates [27, 65, 83]. By contrast, in vivo
studies with Doppler echocardiography have reported no
sex differences in functional parameters such as ejection
fraction and fractional shortening in CD1 mice [104]. How-
ever, these in vivo results could be affected by the use of
anaesthetics, which can alter cardiac function by decreasing
heart rate and may abolish any sex differences that are
present. Furthermore, indices such as ejection fraction and
fractional shortening depend on LV loading status, which
may differ between males and females. This may also mask
sex differences in cardiac function.
Most experimental studies in hearts and cardiac muscle
preparations have revealed lower myocardial contractile
function in females. Sex differences in cardiac contractile
function are likely to arise, at least in part, through differ-
ences in the ability of individual cardiomyocytes to contract.
As cardiac contractions result from a transient rise in intra-
cellular Ca2+ levels in cardiomyocytes [4, 35], they may
reflect underlying sex differences in intracellular Ca2+ han-
dling at the cellular level. The sequence of events that link
cardiac excitation to Ca2+ release from the sarcoplasmic
reticulum (SR) and contraction is known as EC coupling.
This process will be briefly reviewed.
Cardiac excitation–contraction coupling
In cardiomyocytes, Ca2+ levels are tightly regulated via the
EC coupling pathway. This pathway converts an electrical
stimulus from the sinoatrial node into a mechanical contrac-
tion, causing the heart to eject blood. In ventricular myo-
cytes, EC coupling is initiated when the action potential
propagated along the cell membrane causes cellular depo-
larization, which activates voltage-sensitive L-type Ca2+
channels and results in an inward Ca2+ current [4]. L-type
Ca2+ channels located within invaginations in the membrane
are closely associated with Ca2+ release channels located on
the SR [97]. These SR Ca2+ release channels are also known
as ryanodine receptors (RyRs). Ca2+ influx triggers SR Ca2+
release by binding to RyRs, resulting in their opening and
the subsequent release of SR Ca2+, which gives rise to Ca2+
transients [37, 38].
The amount of Ca2+ released from the SR is much larger
than the trigger Ca2+ that enters the cell, a phenomenon known
as Ca2+-induced Ca2+ release. The degree of amplification of
Ca2+ influx to the resulting amount of Ca2+ released from the
SR can be quantified by measuring a parameter known as EC
coupling “gain”. Experimentally, gain is calculated as the ratio
of the amount of SR Ca2+ released (Ca2+ transient) per unit of
Ca2+ current [6]. Factors such as elevated SR Ca2+ load, a
decrease in temperature or ß-adrenergic stimulation have been
shown to increase the gain of cardiac EC coupling [42, 100,
112]. By contrast, H-89, which inhibits protein kinase A
(PKA), reduces the gain of EC coupling [81]. Therefore,
modulation of EC coupling gain can potentially augment or
inhibit SR Ca2+ release and contraction independently of
changes in Ca2+ influx.
The rise in intracellular Ca2+ concentration caused by the
Ca2+ transients allows Ca2+ to bind to the myofilaments,
specifically troponin C, ultimately resulting in contraction
of the myocyte [4, 35]. Relaxation occurs when the majority
of Ca2+ is sequestered into the SR via the sarco/endoplasmic
reticulum Ca2+-ATPase (SERCA), while a much smaller
amount of Ca2+ is removed from the cell predominantly by
the Na+/Ca2+ exchanger (NCX) [89]. Ca2+ reuptake in the
SR is regulated by phospholamban (PLB), which inhibits
SERCA. It is this tightly regulated sequence of events that
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mediates the synchronous contraction of cardiomyocytes,
and thus must be considered when evaluating cardiac con-
tractile function in males and females.
SR Ca2+ is released in the form of discrete, subcellular
Ca2+ release units called Ca2+ sparks. Ca2+ sparks are
thought to result from the activation of a cluster of 6 to 20
RyR channels complexed with an L-type Ca2+ channel [20,
62], and many of these release units will fuse to form Ca2+
transients [49]. Spontaneous Ca2+ sparks can also occur in
quiescent myocytes in the absence of L-type Ca2+ channel
openings [20, 41]. The frequency and amplitude of sponta-
neous Ca2+ sparks is increased with increasing SR Ca2+ load
[94]. In fact, spontaneous Ca2+ sparks are thought to repre-
sent a leak pathway to limit SR Ca2+ content under con-
ditions of SR Ca2+ overload [94]. Changes in the properties
of individual Ca2+ sparks, such as their size and frequency,
can affect Ca2+ transient amplitudes, as well as SR Ca2+
content. Comparison of these unitary Ca2+ release events,
between males and females for example, can reveal unique
Ca2+ handling characteristics of individual cardiomyocytes.
One important pathway in the regulation of EC coupling in
cardiomyocytes is the cyclic adenosine monophosphate
(cAMP)/PKA pathway. Upon activation of the β-adrenergic
receptor, adenylyl cyclase will increase the conversion of ATP
into cAMP, which will activate PKA. PKA phosphorylates
various components of the EC coupling pathway and causes
an increase in inotropy and lusitropy [5]. L-type Ca2+ channel
phosphorylation will increase the size of the Ca2+ current [59],
thus causing a larger Ca2+-induced Ca2+ release from the SR
[5]. Phosphorylation of PLB alleviates its inhibition on
SERCA activity and increases SR Ca2+ uptake, resulting in a
faster Ca2+ transient decay [67]. Phosphorylation of troponin I
causes faster relaxation by promoting dissociation of Ca2+
from the myofilaments [127]. A second protein kinase impli-
cated in the regulation of cardiac contractile function is the
Ca2+-calmodulin-dependent kinase II (CaMKII). CaMKII al-
so phosphorylates various components of the EC coupling
pathway to cause an increase in lusitropy and inotropy, though
to a lesser extent than PKA [5, 17, 126]. As PKA and CaMKII
increase contraction size by increasing the size of the Ca2+
transients, these pathways are important to consider when
examining contractile function in individual myocytes. Sex
differences in either of these kinases could contribute to differ-
ences in SR Ca2+ release and contraction in cardiomyocytes
from males and females.
Contractile function in isolated ventricular myocytes
from males and females
Over the past decade, a number of studies have investigated
whether sex differences in the ability of individual cardio-
myocytes to contract contribute to the differences in cardiac
contractile function reported in studies of intact heart and
isolated cardiac muscle preparations. Some studies in field
stimulated rat ventricular myocytes have reported either no
difference in peak contraction between males and females
[113] or an increase in contraction in cells from females
[96], although this latter study found that sex differences
were abolished when external Ca2+ levels were increased.
However, as shown in Table 1, these studies were performed
at room temperature, rather than at 37 °C, and myocytes
were paced at stimulation frequencies between 0.5 and
0.8 Hz, which is far below the physiological heart rate in
rats [98]. Other studies have used physiological or close to
physiological stimulation frequencies (e.g. 1 to 4 Hz) to
investigate sex differences in cardiac contractile function at
the cellular level. Figure 1a depicts representative examples
of contractions, Ca2+ transients and Ca2+ currents recorded
simultaneously in voltage clamp experiments by Farrell et
al. [40]. Mean data from this study shows that peak con-
tractions are significantly smaller in ventricular myocytes
from female rat hearts in comparison to cells from males
(Fig. 1b). Additional field stimulation and voltage clamp
experiments have revealed that cells from young adult fe-
male rats have smaller and slower contractions in compari-
son to age-matched males [29, 40, 55]. Whether this applies
to all species is not clear, as one study performed in mice
reported no sex difference in myocyte contraction size [46].
Studies examining contraction and relaxation of isolated
ventricular myocytes from male and female rats are summa-
rized in Table 1. Taken together, most studies show that sex
differences in cardiac contraction are present at the cellular
level, in particular if myocytes are paced at physiological
rates. As cardiomyocyte contraction is proportional to pac-
ing frequency in cells from rodents [68], it is perhaps not
surprising that sex differences in cardiac contractile function
are more apparent at rapid pacing rates. Further, as discussed
earlier, studies in intact hearts, papillary muscles and ven-
tricular trabeculae found that sex differences were more
prominent at rapid stimulation rates. These results support
the conclusion that sex differences in cardiac contractility
are due, at least in part, to differences in the ability of
individual cardiomyocytes to contract.
Sex differences in the contraction size of individual car-
diomyocytes could arise from differences in the contractile
machinery in cells from males and females. Therefore, the
abundance and properties of myofilament proteins have
been compared in male and female hearts. Female rat ven-
tricles have been reported to possess higher levels of both α-
and β-myosin heavy chain (MHC) and of sarcomeric actin
mRNA in comparison to males [92]. However, there is no
sex difference in the ratio of α- to β-MHC [92]. Even so, the
possibility remains that there are sex differences in the rate
of translation or in post-translational modifications of MHC
proteins, and this could be evaluated with newer experimen-
tal approaches.
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To determine whether there were functional differences
in myofilaments from male and female hearts, Petre et al.
[83] compared the Ca2+ sensitivity of myofilaments in
skinned ventricular trabeculae from cats of both sexes. They
compared maximal force in response to increasing concen-
trations of Ca2+ and found no sex difference in either the
maximal force generated or in the concentration of Ca2+
required to produce 50 % of maximal force (EC50 values).
Similarly, Schwertz et al. [96] found that the maximal de-
veloped force did not differ in skinned muscle fibres from
male and female rats. However, myofibrillar ATPase activity
was higher in females at any given Ca2+ concentration,
which suggests that contractile proteins in female hearts
may have greater Ca2+ sensitivity when compared to males
[96]. Therefore, it is possible that the contractile machinery
within female rat hearts is actually more sensitive to Ca2+,
and thus responds to lower intracellular Ca2+ concentrations
than males. Certainly, there is no evidence that reduced
myofilament responsiveness to Ca2+ explains the smaller
contractions characteristic of myocytes from female hearts.
Further research is required to confirm this finding, and to
determine whether this is true in other animal models, as
well as in humans.
Sex differences in Ca2+ transients in isolated ventricular
myocytes
The amplitude of cardiac contraction depends not only on
the myofilaments but also on the magnitude of the rise in
intracellular Ca2+ [5]. Thus, the smaller contractions char-
acteristic of cardiomyocytes from female animals may arise
from sex differences in the size of the underlying Ca2+
transients. Figure 1a (top panel) depicts representative
Ca2+ transients recorded in voltage clamp experiments from
myocytes from young adult male and female rats [40]. As
shown in this figure and in the mean data in Fig. 1c, peak
Ca2+ transients are larger in cardiomyocytes from male
hearts in comparison to female hearts. In fact, many studies
using either field stimulation or voltage clamp techniques
have determined that ventricular myocytes from female rats
have smaller Ca2+ transient amplitudes in comparison to
cells from males [29, 40, 65, 114]. By contrast, other inves-
tigations have reported no difference in Ca2+ transient
amplitudes between the sexes in both mouse and rat models
[46, 55, 124]. Differences in pacing frequency, temperature
and/or species are known to affect intracellular Ca2+ han-
dling [33, 86, 100], and variations in these parameters
between studies may help explain these divergent results.
Additional factors such as diastolic Ca2+ levels may also be
important, as discussed below.
There is growing experimental evidence that contractions
are substantially smaller in ventricular myocytes from
females than males, in particular when cells are paced at
rapid rates. However, the corresponding changes in peak
Ca2+ transients are less dramatic, and some studies even
report no sex difference in Ca2+ transient amplitudes [46,
55, 124]. It is important to note that the magnitude of cardiac
contractions depends not only on the peak Ca2+ transients
but also on the level of resting (diastolic) Ca2+ in the cell [4,
99]. For the same amount of activating Ca2+, higher levels
of diastolic Ca2+ result in larger contractions [4, 99]. Inter-
estingly, diastolic Ca2+ levels are significantly lower in
cardiomyocytes from female rats when compared to male
rats [40, 55], although no sex differences are seen in murine
myocytes [46]. Additional experiments that explore sex
differences in cardiomyocytes exposed to varying diastolic
Ca2+ levels could determine if lower diastolic Ca2+ levels
are contributing to smaller contractions in females.
It is well established that Ca2+ transients in isolated
cardiomyocytes from female rats have slower decay rates
when compared to males [29, 65, 114]. A reduction in the
rate of Ca2+ transient decay suggests that the rate of Ca2+
reuptake into the SR must be slower in myocytes from
females. To investigate this possibility, expression levels of
the major SR Ca2+ ATPase cardiac isoform, SERCA2a,
have been compared in ventricles from male and female
rats. No differences in either SERCA2a protein or mRNA
levels in the ventricles of male and female rats have been
Table 1 Contractile function in
isolated ventricular myocytes
from female rats in relation to
responses in cells from males
Functional change Model Frequency (Hz) [Ca2+] (mM) Temperature (°C) References
↓ Shortening Rats 2 1 37 [40]
↔ Relaxation
↓ Shortening Rats 2, 4 1 37 [55]
↔ Relaxation
↓ Shortening Rats 1 0.5–2 25 [29]
Slower relaxation
↑ Shortening Rats 0.5 1.5 Room temperature [96]
↔ Relaxation
↔ Shortening Rats 0.5 3.5 Room temperature [96]
Slower relaxation
↔ Shortening Rats 0.8 1 – [113]
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observed [19, 23, 106]. PLB, the intrinsic regulator of
SERCA, was also evaluated in hearts from male and female
rats. Similar levels of PLB protein and mRNA expression
were found in the ventricles of both males and females [19,
23, 106]. Therefore, differences in the rate of decay of the
Ca2+ transients are not due to alterations in SERCA2a or
PLB protein levels. Future work should determine whether
post-translational modifications that alter the activity of
SERCA2a or PLB differ between the sexes.
One area that requires further investigation is differences
in the cAMP/PKA pathway in cardiomyocytes from males
and females. Activation of this pathway plays an important
role in increasing SR Ca2+ release and contraction size.
Thus, in theory, sex differences in cAMP levels, PKA ac-
tivity or other components of this pathway could contribute
to the observed sex differences in components of cardiac EC
coupling. For example, phosphorylation of PLB via PKA is
known to accelerate relaxation of ventricular myocytes [67].
Fig. 1 Mechanisms of cardiac
EC coupling differ between the
sexes. a Sample recordings of
Ca2+ transients (top),
contractions (middle) and Ca2+
current (bottom) in ventricular
myocytes from 3-month-old
male and female rats.
Responses were simultaneously
activated by a voltage clamp
test step from −40 to 0 mV. b, c
Contractions and Ca2+
transients were significantly
smaller in myocytes from
females when compared to
males. d SR Ca2+ content,
evaluated by the rapid
application of 10 mM caffeine,
was similar in the two groups.
e, f Ca2+ spark frequency did
not differ between the sexes,
but Ca2+ spark amplitudes were
smaller in cells from females
when compared to males. g
Peak Ca2+ currents were similar
in myocytes from males and
females. h The gain of EC
coupling (SR Ca2+ release per
unit Ca2+ current) was much
lower in cells from females
compared to males. Reprinted
from Farrell et al. [40] with
permission
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Reduced levels of phosphorylated PLB could diminish
SERCA2a activity and account for the slower rates of
Ca2+ transient decay characteristic of ventricular myocytes
from female hearts in comparison to males. Similarly, a
decrease in PLB phosphorylation by CaMKII could account
for the slower rate of decay of Ca2+ transients in females.
Further investigation of these pathways in cardiomyocytes
from male and female animals may be helpful in under-
standing the cellular basis for sex differences in cardiac
contractile function.
SR Ca2+ handling in cardiomyocytes from males and females
The magnitude of cardiac contractions and underlying Ca2+
transients depends upon SR Ca2+ content [6]. If cells from
female hearts have lower SR Ca2+ content than males, then
this could explain why less Ca2+ is released upon depolariza-
tion. Therefore, several studies have evaluated the possibility
that the amount of SR Ca2+ available for release differs be-
tween the sexes. These studies have measured SR Ca2+ con-
tent by rapidly applying 10–20 mM caffeine to
cardiomyocytes. Figure 1d shows mean results obtained by
Farrell et al. [40]. Mean peak caffeine-induced Ca2+ transients
were similar in cardiomyocytes from male and female rats.
Other studies in rats have shown that SR Ca2+ stores are
similar in cardiomyocytes from males and females [19, 29,
40, 55, 124]. By contrast, one study in guinea pig ventricular
myocytes showed that SR Ca2+ content was, in fact, higher in
myocytes from females when compared to cells from age-
matched males [73]. Therefore, there is considerable evidence
that SR Ca2+ content is either similar in cardiomyocytes from
males and females or is actually higher in myocytes from
female animals, depending upon the species examined. These
findings demonstrate that lower SR Ca2+ content is unlikely to
be responsible for smaller Ca2+ transients that are observed in
myocytes from female animals.
To determine whether differences in the abundance of the
major SR Ca2+ release channel (RyR2) could account for
differences in SR Ca2+ release between the sexes, several
studies have measured RyR2 expression levels in rat ven-
tricles. Interestingly, RyR2 protein and mRNA levels are
significantly higher in females when compared to males [23,
124]. Therefore, a reduction in the level of RyR2 protein
does not account for the smaller Ca2+ transient amplitudes in
cardiomyocytes from females. Alternatively, sex differences
in Ca2+ transients could be explained by alterations in the
magnitude and/or duration of individual SR Ca2+ release
units (Ca2+ sparks) from RyR2 channels. To investigate this
possibility, Farrell et al. [40] compared spontaneous Ca2+
sparks in quiescent myocytes from male and female rats.
Figure 1e shows that mean Ca2+ spark amplitudes were
significantly smaller in cells from females when compared
to males [40]. However, this study also found that there
were no differences between the sexes when spark frequen-
cy (Fig. 1f) or spark width (not shown) was examined.
Females also exhibited lower SR Ca2+ spark durations
(time-to-peak and decay time) when compared to males
[40]. By contrast, the only other study to examine Ca2+
sparks in males and females contradicted these results, and
reported an increase in both Ca2+ spark amplitude and
duration in myocytes from female rats [124]. However, this
latter study was performed at room temperature, while Far-
rell et al. [40] examined Ca2+ sparks at physiological tem-
perature. Previous work has shown that Ca2+ sparks
recorded at room temperature are larger, have longer dura-
tions and occur more frequently when compared to sparks
recorded at physiological temperature [41]. It is possible
that, in the study by Yaras et al. [124], cooling may have
masked sex differences that would be present at physiolog-
ical temperature in vivo. This is important to consider be-
cause many contemporary studies of EC coupling are still
conducted at room temperature, which represents a condi-
tion of profound hypothermia that influences many aspects
of cardiac EC coupling [100].
If Ca2+ sparks are indeed smaller and shorter in myocytes
from females, this offers valuable insight into the subcellular
basis for sex differences in SR Ca2+ release and contraction.
Smaller Ca2+ sparks would be expected to summate and
give rise to smaller Ca2+ transients in cardiomyocytes from
females. As the amount of Ca2+ released during a spark is
regulated by the intrinsic gating of the RyR2 [16], sex
differences in the opening of individual RyR2 channels
could be responsible for smaller Ca2+ transients in males.
Thus, an important area for future research is determining
whether there are sex differences in the gating of RyR2
channels in the SR. Alternatively, as RyR2 levels are actu-
ally higher in females [23, 124], it is possible that there are
post-translational modifications in males that could contrib-
ute to increased SR Ca2+ release by increasing channel
opening. Phosphorylation by PKA or CaMKII has been
shown to increase the Ca2+-dependent activation and open-
ing of RyRs [5, 126]. As such, reduced SR Ca2+ release in
myocytes from female hearts could be a result of a lower
level of basal PKA or CaMKII activation. Even in the
absence of β-adrenergic receptor stimulation, lower basal
PKA or CaMKII activity could cause less RyR2 phosphor-
ylation and suppress SR Ca2+ release. Future research into
the cAMP/PKA and CaMKII pathways in male and female
hearts could be helpful in understanding the cellular basis
for sex differences in EC coupling.
Myocytes from male animals respond to isoproterenol, a
non-selective β-adrenergic receptor agonist, with a larger
increase in contractions, Ca2+ transient amplitudes and Ca2+
current in comparison to females [29, 113]. Isoproterenol
also causes a larger increase in diastolic Ca2+ and SR Ca2+
content in cardiomyocytes from males [19, 29]. These
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effects may be explained by the observation that isoproter-
enol increases cAMP levels substantially more in cardio-
myocytes from males than females [113]. This would cause
a greater activation of PKA in male hearts than in females,
and thus higher levels of phosphorylation of relevant targets
such as L-type Ca2+ channels, RyR2 and PLB. Further
studies are required to fully understand the mechanisms that
underlie sex differences in responses to β-adrenergic recep-
tor activation and to determine whether these mechanisms
contribute to sex differences in EC coupling even in the
absence of β-adrenergic stimulation.
Electrophysiological studies of EC coupling in ventricular
myocytes from males and females
It has been well documented that the size of the Ca2+
transients in ventricular myocytes is directly proportional
to the magnitude of the L-type Ca2+ current [6]. To deter-
mine whether smaller Ca2+ transients in females could be
explained by a decrease in Ca2+ current density, Ca2+ cur-
rents have been compared in myocytes from males and
females. Representative Ca2+ current recordings from volt-
age clamp experiments in ventricular myocytes from male
and female rats are shown in the lower panel of Fig. 1a [40].
Mean data clearly show that there is no sex difference in
Ca2+ current density (Fig. 1g). Indeed, most investigations
utilizing ventricular myocytes from rats, mice or guinea pigs
have reported no sex difference in Ca2+ current density [9,
40, 46, 55, 65, 124]. In addition, a few studies in various
animal models have reported that Ca2+ current density is
actually higher in myocytes from females in comparison to
males [73, 113, 123]. Taken together, there is considerable
evidence that a reduction in Ca2+ current density does not
explain the smaller Ca2+ transients and contractions ob-
served in cardiomyocytes from female animals.
Only one study has reported that Ca2+ current density is
lower in myocytes from female guinea pigs [56]. However,
this study was designed to determine whether Ca2+ current
density fluctuated with the oestrous cycle and therefore
utilized female guinea pigs that were cycling regularly.
Interestingly, they found that Ca2+ current differed between
the sexes only on day 4 of the oestrous cycle, which corre-
sponds to the peak in plasma progesterone-to-estradiol lev-
els [56]. However, the influence of the oestrous cycle may
not be a factor in most experimental studies, as female
rodents housed in groups typically do not cycle regularly
[1, 74, 119] unless they are induced to cycle by exposure to
the pheromones present in male urine [118]. Still, the oes-
trous stage may be an important variable to consider in
studies of female animals if they are exhibiting regular
oestrous cycles.
A number of investigations have used molecular
approaches to determine whether L-type Ca2+ channel
expression differs in male and female myocardium. The
levels of mRNA for CaV1.2, a subunit of the L-type Ca
2+
channel, have been evaluated in hearts from males and
females. There is little agreement on whether CaV1.2
mRNA levels differ between the sexes, as levels have been
shown to increase, decrease or not change at all in ventricles
from females when compared to males [23, 102, 106],
reflecting inherent limitations in such an approach. A more
direct approach is to evaluate the levels of CaV1.2 protein
expression in hearts from males and females. These studies
showed that female animals have significantly higher levels
of CaV1.2 protein in comparison to males [23, 102]. Simi-
larly, Vizgirda et al. [113] used a radioligand binding ap-
proach and reported an increase in the density of
dihydropyridine receptors (L-type Ca2+ channels) in the
ventricles of female rats. If females do have higher levels
of CaV1.2, it is interesting that most studies have found that
Ca2+ current density does not differ between the sexes. It is
possible that there are sex differences in the activity of
individual L-type Ca2+ channels. For example, if myocytes
from male animals had a higher basal level of PKA activa-
tion, then this would result in more Ca2+ channel phosphor-
ylation that could compensate for the decrease in Ca2+
channel expression. Future research should focus on this
possibility, as well as other post-translational modifications
that may give rise to sex differences in EC coupling.
When cardiomyocytes are regularly paced to reach steady
state, Ca2+ efflux from the cytosol must match the Ca2+
entering the cytosol upon depolarization [7]. The primary
mechanism responsible for Ca2+ efflux is the NCX, so
studies have compared the abundance and activity of the
NCX in hearts from males and females. One study found no
difference in the NCX current in ventricular myocytes iso-
lated from male and female pig hearts [117]. Conversely,
studies in the rabbit model have found an increase in NCX
current in myocytes from the base of female ventricles when
compared to males [18]. In addition, the expression of
NCX1 protein, the major cardiac NCX isoform, is increased
in female rabbit hearts [18]. These results are supported by
two other studies that showed an increase in NCX protein
and mRNA levels in myocytes from female rats in compar-
ison to males [23, 106]. Taken together, these results suggest
that both the level of NCX expression and its activity are
higher in females than in males, at least in the rat model.
Higher NCX activity could contribute to the lower diastolic
Ca2+ concentrations and smaller Ca2+ transients observed in
myocytes from female rats.
Most of the evidence available to date indicates that Ca2+
current density is similar in cardiomyocytes from males and
females, but contractions and Ca2+ transients are smaller in
females. This suggests that the “gain” of EC coupling,
which is the amount of SR Ca2+ released per unit Ca2+
current, may be lower in cardiomyocytes from females. To
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directly explore this idea, Farrell et al. [40] measured the
gain of EC coupling in voltage clamp experiments where
Ca2+ current density and Ca2+ transients were measured
simultaneously. They found that gain was substantially low-
er in female rat ventricular myocytes when compared to age-
matched males. Mean data from this study are shown in
Fig. 1h. These data show that less SR Ca2+ is released in
response to a given trigger Ca2+ stimulus in myocytes from
females than in males. As previously suggested, future
research should examine the possibility that males possess
increased phosphorylation levels as a result of higher PKA
or CaMKII activity. This could potentially explain the larger
SR Ca2+ release in response to the same amount of trigger
Ca2+. Alternatively, it has been suggested that sex steroid
hormones are responsible for the decrease in EC coupling
gain in female myocytes in comparison to males [71]. Fur-
ther understanding of the cardiomyocyte pathways activated
by the major sex steroid hormones is required.
The data reviewed above indicate that sex differences in
EC coupling are likely due to alterations in the regulation of
SR Ca2+ release, rather than differences in Ca2+ influx, at
least when cells are activated by identical square pulses in
voltage clamp experiments. However, SR Ca2+ release and
cardiac contraction in vivo are triggered by an action poten-
tial, not a square voltage clamp waveform. Investigations in
various animal models have compared action potential char-
acteristics between the sexes. Studies in cardiomyocytes
from C57BL/6 mice, rats and guinea pigs have found that
action potential durations at 50 % and 90 % repolarization
(APD50 and APD90) are similar in males and females [9, 10,
40, 65]. However, this finding has not been observed in all
studies. APDs are prolonged in CD-1 female mice when
compared to males [109]. APD is also prolonged in ventric-
ular myocytes from the midmyocardium of female dogs
[123]. There is evidence that ventricular myocytes from
female guinea pigs have longer APDs than males [73],
although another study found longer APDs in females only
when the animals were in the “oestrus” stage, where estra-
diol levels had peaked [56]. Interestingly, prolongation of
the APD in female mice is also most readily apparent when
mice are in the “oestrus” stage [93]. Differences in the
species used, source of the ventricular myocytes used and/or
the oestrous stage may account for these divergent results.
Nonetheless, these studies show that APD is either similar in
cardiomyocytes from males and females or that it is pro-
longed in females. As prolongation of the action potential
increases Ca2+ influx [25], this may help compensate for the
reduction in SR Ca2+ release in female myocytes in vivo.
Additional experiments to explore the relationship between
APD and myocardial Ca2+ handling in myocytes from males
and females are needed. Important functional differences in
cardiac EC coupling mechanisms in myocytes from female
rodents in comparison to males are summarized in Fig. 2.
The impact of sex steroid hormones on cardiac EC
coupling mechanisms
The risk of cardiovascular disease is lower in pre-menopausal
women in comparison to age-matched men; this difference
disappears as early as 5 years post-menopause [8, 53, 54]. As
menopause is marked by a decrease in the production of
ovarian hormones, it is thought that female sex hormones
are cardioprotective, and their decline contributes to the in-
creased risk of cardiovascular disease during the aging process
[69]. Indeed, there is some evidence that hormone replace-
ment therapy reduces the risk of cardiovascular disease in
post-menopausal women, although this is controversial [78].
It is less often appreciated that men also experience an age-
dependent decline in the levels of sex hormones during andro-
pause, at the same time as their risk of cardiovascular disease
rises [30, 61]. Testosterone supplementation, which is current-
ly used to treat various conditions linked to low androgen
states, is being explored for the treatment of cardiovascular
diseases [61]. These observations have led to considerable
interest in the mechanisms by which sex steroid hormones
may modify cardiovascular function.
The knowledge that individual cardiomyocytes possess
receptors for all three major sex steroid hormones (oestro-
gen, progesterone and testosterone) has led to the idea that
effects of sex hormones on the myocytes themselves may be
important in understanding their role in cardiovascular dis-
ease [30, 79]. Sex hormones are thought to act via specific
receptors to elicit both non-genomic (acute) and genomic
(chronic) effects on cardiac contractile function [30, 79]. As
such, it is possible that sex hormones play an important role
in mediating the sex differences in EC coupling observed in
cardiomyocytes from male and female animals. The follow-
ing discussion will first consider acute and chronic effects of
female sex hormones on cardiac function. This will be
followed by consideration of the impact of male sex hor-
mones on the heart.
Acute effects of female sex hormones on EC coupling
As neonatal and adult cardiomyocytes possess oestrogen
receptors [47, 91], there has been considerable interest in
the acute (non-genomic) effects of oestrogen on cardiomyo-
cyte function. Therefore, a number of studies have explored
the effects of acute administration of oestrogen on compo-
nents of the EC coupling pathway. It is well established that
acute application of supra-physiological concentrations (e.g.
0.1 to 100 μM) of the major female sex steroid hormone,
17β-estradiol, to ventricular myocytes causes a marked
reduction in the magnitude of the Ca2+ current in myocytes
from mice, rats, guinea pigs, rabbits and even humans [3, 57,
77, 105, 110]. Meyer et al. [77] showed that 10 μM 17β-
estradiol elicited a similar inhibitory action on the Ca2+ current
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in cells from humans, guinea pigs and rats, regardless of
whether the cells were from males or females. Acute
application of high concentrations (10 to 30 μM) of
17β-estradiol also reduces the amplitudes of Ca2+ tran-
sients and contractions in isolated ventricular myocytes
[57, 110]. Interestingly, stimulation of oestrogen recep-
tor α with PPT (4,49,499-(4-propyl-[1H]-pyrazole-1,3,5-
triyl) trisphenol; 100 nM) has been shown to decrease
myofilament Ca2+ sensitivity [64]. There is also evi-
dence that oestrogen can acutely modify electrophysio-
logical properties of the heart. Langendorff-perfused
female rabbit hearts [21] showed that 17β-estradiol
(1 to 30 μM) prolonged APD and increased the inci-
dence of arrhythmias induced by the Class III antiar-
rhythmic drug, sotalol. These studies provide evidence
that acute application of supra-physiological concentra-
tions of 17β-estradiol can affect components of the EC
coupling pathway. However, serum concentrations of
17β-estradiol range from 70 to 1,300 pM depending
upon the menstrual cycle in premenopausal women [30].
Serum estradiol levels are reported to be even lower
in rodent models and are very difficult to accurately
and consistently measure [51, 75, 93, 121]. Even so,
all studies of the acute effects of oestrogen on cardio-
myocytes to date have utilized very high concentrations
of 17β-estradiol. It would be interesting to investigate
acute effects of picomolar concentrations of 17β-estradiol in
vitro.
The other major female sex hormone is progesterone, and
previous studies have shown that progesterone receptors are
also present on cardiomyocytes [45]. There is some evi-
dence that the acute application of progesterone can affect
various components of the EC coupling pathway. One study
found that acute treatment with very high concentrations of
progesterone (1 to 3 μM) increased APD in Langendorff-
perfused female rabbit hearts [21]. By contrast, lower con-
centrations of progesterone (e.g. 100 nM) have been shown
to reduce APD in cardiomyocytes isolated from female
guinea pigs [80]. This effect was found to be due mainly
to a progesterone-mediated increase in the magnitude of the
Fig. 2 Differences in the major
components of cardiac excitation–
contraction (EC) coupling in
ventricular myocytes from female
animals in comparison to males.
L-type Ca2+ current density does
not differ between males and
females, although NCX activity is
higher in myocytes from females.
However, Ca2+ transient
amplitudes and SR Ca2+ spark
amplitudes are decreased in
females in comparison to males.
Therefore, females have lower EC
coupling gain (Ca2+ transient per
unit Ca2+ current). Female
myocytes have smaller
contractions in comparison to
males. Contractions are also
slower to relax in female
myocytes, which is likely a result
of reduced SR Ca2+ uptake via
SERCA. Additionally, APD is
either unchanged or prolonged in
myocytes from females in
comparison to cells from males.
These sex differences in EC
coupling are thought to contribute
to reduced contractile function in
myocytes from females in
comparison to males. APD action
potential duration,NCXNa+–Ca2+
exchanger, PLB phospholamban,
RyR ryanodine receptor, SERCA
sarcoplasmic/endoplasmic
reticulum Ca2+ ATPase, SR
sarcoplasmic reticulum
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slow delayed rectifier K+ current (IKs), which is an
important contributor to cellular repolarization [80]. Pro-
gesterone (100 nM) also attenuates the increase in L-
type Ca2+ current that occurs in response to β-
adrenergic stimulation with isoproterenol [80]. Together,
these studies suggest that relatively high concentrations
of progesterone (0.1 to 3 μM) can affect myocardial function
at the cellular level. However, these studies have all utilized
relatively high concentrations of the hormone; circulating
levels of progesterone range from 1 to 64 nM in premeno-
pausal women [30] and between 3 and 55 nM in rodents [60,
121]. Whether lower concentrations of progesterone affect the
contractile function of cardiomyocytes in vitro should be
further examined.
The impact of ovariectomy on EC coupling
Inferences about the effects of chronic exposure to gonadally
derived oestrogen on cardiac function have been drawn from
investigations where animals have been subjected to bilateral
ovariectomy (OVX), in the absence and/or presence of oestro-
gen replacement. Bilateral OVX causes a dramatic reduction in
circulating levels of the primary female sex hormone, 17β-
estradiol [22, 34, 58, 88, 122]. Several studies have compared
contractile function in ventricular myocytes isolated from
sham-operated and OVX rodents, with conflicting results.
Two studies found an increase in contraction size in cells from
OVX rats in comparison to sham controls after 3–6 weeks of
steroid withdrawal [28, 122]. By contrast, contractions were
reported to be smaller in myocytes isolated from rats follow-
ing 9–10 weeks of steroid withdrawal [14, 88]. Results from
these studies are summarized in Table 2. Interestingly, in all
cases, these effects of OVX on cardiac contractile function
were reversed when 17β-estradiol was replaced [14, 28, 88,
122]. It is not clear why differing results were obtained in
these studies, but it is possible that the time frame of steroid
withdrawal is important in the observed effects on cardiac
contraction at the cellular level. Additional investigation of
the impact of varying time periods of OVX may be revealing.
A number of studies also have investigated whether OVX
affects SR Ca2+ release at the level of the cardiomyocyte.
Figure 3a shows mean results obtained by Fares et al. [39]
from voltage clamp experiments performed on isolated car-
diomyocytes from sham-operated and OVX mice. These
data show that OVX causes a marked increase in mean peak
Ca2+ transients in myocytes from OVX animals when com-
pared to sham controls. Most other investigations in the rat
model have also shown that peak Ca2+ transient amplitudes
are increased by OVX when compared to sham-operated
controls, and this effect is reversed by 17β-estradiol replace-
ment [28, 39, 63, 70]. Together, these studies have investi-
gated periods of hormone withdrawal as short as 3 weeks
and as long as 26 weeks (Table 2), suggesting that the period
of hormone restriction may not affect the observed results
[28, 39, 63, 70]. In contrast to these findings, two studies
have reported that peak Ca2+ transients are either unchanged
or reduced following OVX in the rat model [14, 88]. How-
ever, these latter studies used slow pacing rates (e.g. 0.5 Hz)
and buffers that contained only 0.5 to 1 mM Ca2+, factors
that have been shown to reduce SR Ca2+ loading and elim-
inate sex differences in cardiac EC coupling [83]. These
factors may have reduced the amount of SR Ca2+ available
for release in OVX myocytes.
Insights into the effects of chronic oestrogen exposure on
cardiac contractile function have also been drawn from
comparisons of myofilament Ca2+ sensitivity in cardiac
tissues from sham-operated and OVX rats. There is good
agreement that myofilament Ca2+ sensitivity is increased in
OVX hearts after 10 weeks of steroid withdrawal when
Table 2 Components of cardiac EC coupling in ventricular myocytes
from OVX animals in relation to responses in sham-operated controls




Contraction ↑ Shortening Rats 3 [28]
6 [122]
↓ Shortening Rats 9 [88]
10 [14]




↔ Amplitude Rats 9 [88]












↑ Stores Rats 6 [63]
Mice 26 [39]
Ca2+ current ↔ Density Mice 26 [39]
Diastolic
Ca2+
↔ Levels Rats 3 [28]
6 [63]
10 [14]
↑ Levels Rats 9 [70]
9 [88]
Mice 26 [39]
NCX current ↑ Density Rats 6 [63]
OVX ovariectomy, NCX Na+ –Ca2+ exchanger, SR sarcoplasmic
reticulum
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compared to sham-operated controls [14, 115, 116]. Further-
more, treatment with oestrogen replacement reversed these
changes in myofilament Ca2+ sensitivity [116]. Together
with the majority of studies that show that OVX increases
SR Ca2+ release, this sensitization of the myofilaments to
Ca2+ would be expected to augment cardiac contractile
function. However, whether OVX increases contraction at
the level of the cardiomyocyte remains controversial and is
an interesting area for additional exploration.
The finding that OVX causes an increase in Ca2+ tran-
sient amplitudes suggests that oestrogen may suppress SR
Ca2+ release. To further examine this possibility, Fares et al.
[39] compared the occurrence and properties of individual
Ca2+ units (spontaneous Ca2+ sparks) in ventricular myo-
cytes from sham-operated and OVX mice. Although spark
duration was unaffected by OVX, they found that spontane-
ous Ca2+ sparks were more frequent and larger in amplitude
in myocytes from OVX mice in comparison to cells from
sham controls (Fig. 3b, c and Table 2). This finding dem-
onstrates that unitary SR Ca2+ release is enhanced by chron-
ic oestrogen withdrawal and suggests that oestrogen may
reduce Ca2+ transient amplitudes by suppressing Ca2+ re-
lease at the level of the individual SR Ca2+ release unit.
Additional experiments to determine whether oestrogen
replacement could reverse these changes would provide
further support for this idea.
One factor that may modify Ca2+ release in OVXmyocytes
is SR Ca2+ content. Thus, SR Ca2+ content has been compared
in cardiomyocytes isolated from sham-operated and OVX
rodents. Fares et al. [39] used the rapid application of
10 mM caffeine to measure SR Ca2+ load. They showed that
OVX increased SR Ca2+ content in murine cardiomyocytes,
as shown in the mean data illustrated in Fig. 3d. Indeed, there
is good agreement that cardiomyocytes from OVX mice and
rats have increased SR Ca2+ stores in comparison to sham-
operated controls [39, 63]. These data indicate that OVX
increases the amount of Ca2+ available in the SR, whichwould
be expected to contribute to the larger Ca2+ transients charac-
teristic of OVX myocytes. This increase in SR Ca2+ content
may explain the increased frequency of Ca2+ sparks in OVX
cells. Spontaneous Ca2+ sparks are thought to be a pathway to
limit SR Ca2+ overload [94], so the increased spark frequency
in OVX cells likely occurs in response to the increase in SR
Ca2+ content.
Elevated SR Ca2+ content can also lead to spontaneous
release of a larger amount of SR Ca2+ and trigger delayed
afterdepolarizations, leading to cardiac arrhythmias [103].
Interestingly, OVX has been shown to promote the
Fig. 3 Ovariectomy modifies components of EC coupling to enhance
SR Ca2+ release in isolated ventricular myocytes. EC coupling mech-
anisms were compared in ventricular myocytes isolated from 8-month-
old female mice that had either a bilateral OVX or sham operation at
1 month of age. Ca2+ transients and Ca2+ currents were activated by a
voltage clamp step from −40 to 0 mV. a Ca2+ transient amplitudes were
significantly larger in myocytes from OVX mice when compared to
sham-operated controls. b, c Spontaneous Ca2+ sparks were larger and
occurred more frequently in OVX myocytes when compared to sham
controls. d OVX increased SR Ca2+ content, as measured via rapid
application of 10 mM caffeine. e Ca2+ current densities were similar in
myocytes from OVX and sham-operated animals. f OVX increased the
gain of EC coupling. Reprinted from Fares et al. [39] with permission
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spontaneous release of SR Ca2+ [39]. This may explain
previous observations that OVX increases arrhythmias in
myocardial ischemia and during adrenergic stimulation [24,
107] and could, in part, explain the increase in risk for
arrhythmias in post-menopausal women [82]. Taken togeth-
er, these results suggest that oestrogen suppresses SR Ca2+
release, limits SR Ca2+ content and inhibits the spontaneous
release of SR Ca2+. This may contribute to the cardiopro-
tective effects of oestrogen observed in both clinical and
laboratory studies.
Since the magnitude of SR Ca2+ release is directly propor-
tional to the amount of Ca2+ entering the cell upon depolar-
ization [6], differences in Ca2+ current between OVX and
sham controls could account for the variability in Ca2+ tran-
sient amplitudes. Previous studies have shown that CaV1.2
protein expression is higher in hearts from OVX rats in
comparison to sham controls [22]. However, Fares et al. [39]
directly measured L-type Ca2+ current in ventricular myocytes
from sham-operated and OVX mice and found that peak Ca2+
currents were similar in the two groups, as shown in Fig. 3e.
Mean data from this study also showed that Ca2+ current
amplitudes were similar in sham and OVX cells across a range
of voltages [39]. This indicates that the increased Ca2+ tran-
sients observed in OVX cardiomyocytes are not a result of
increased Ca2+ influx. In fact, the same study reported that
OVX increased the gain of EC coupling in comparison to
sham controls, as shown in Fig. 3f [39]. Overall, these studies
suggest that female sex steroid hormones, such as oestrogen,
reduce SRCa2+ release bymodifying the gain of EC coupling,
not by suppressing Ca2+ influx.
Whether OVX affects resting Ca2+ levels in isolated
cardiomyocytes has been investigated in a number of stud-
ies, as summarized in Table 2. When diastolic Ca2+ levels
were quantified 3 to 6 weeks after OVX, diastolic Ca2+
levels were similar in sham and OVX myocytes [28, 63].
One study has reported that diastolic Ca2+ levels were
unchanged even 10 weeks after OVX [14], although most
studies that looked at longer times after OVX (e.g. 9 to
26 weeks) found that diastolic Ca2+ levels were higher in
cardiomyocytes from OVX animals in comparison to sham
controls [39, 70, 88]. These findings suggest that prolonged
periods of oestrogen withdrawal may increase resting Ca2+
levels in ventricular myocytes. This could promote impaired
relaxation and diastolic dysfunction in older female hearts
that are chronically exposed to lower ovarian hormone
levels, and further studies of this are warranted.
Elevated diastolic Ca2+ suggests that Ca2+ extrusion mech-
anisms may be compromised by OVX. Thus, several studies
have evaluated whether OVX modifies Ca2+ handling by
affecting Ca2+ sequestration and/or removal mechanisms.
There is evidence that the levels of SERCA2a protein are
unchanged after OVX [22, 63, 88], although two studies have
found that SERCA2a levels decline following longer periods
of hormone withdrawal (e.g. 10 weeks [12, 13]). However,
whether this impairs SR Ca2+ sequestration has not been
established. While total PLB and phospho-Ser16 PLB are not
affected by OVX, phospho-Thr17 PLB has been shown to
decrease with OVX [12, 13], which could actually enhance
SR Ca2+ uptake. Additional studies to clarify this issue would
be of interest. There is no evidence that NCX protein levels are
increased by OVX [22, 63], although functional studies have
reported an increase in NCX activity in cardiomyocytes iso-
lated from rats 6 weeks after OVX [63]. This would be
expected to promote Ca2+ extrusion and reduce resting Ca2+
levels, at least in the short term. Whether this persists with
longer periods of ovarian hormone withdrawal has not yet
been determined.
To elucidate the molecular mechanisms responsible for
enhanced SR Ca2+ release following OVX, several studies
have examined the contribution of phosphorylation of EC
coupling components. Application of isoproterenol causes a
greater increase in Ca2+ current, Ca2+ transients and PKA
activity in myocytes from OVX rats compared to sham
controls [58]. This may be due, at least in part, to the higher
levels of β1-adrenergic receptors observed in OVX cardio-
myocytes [108, 122]. Even acute application of physiolog-
ical concentrations of 17β-estradiol (0.1 to 1 nM) attenuates
the increase in cAMP levels caused by isoproterenol appli-
cation [66]. Although no basal differences in cAMP levels
are observed, myocytes from OVX rats have increased basal
PKA expression and activity [58, 63]. Interestingly, Kravt-
sov et al. [63] showed that pharmacological inhibition of
basal PKA abolished the increase in SR Ca2+ release in
myocytes from OVX rats. Furthermore, the basal increase
in PKA activity was abolished when OVX rats were chron-
ically treated with oestrogen replacement [58]. This sug-
gests that oestrogen may attenuate PKA expression and/or
activity in cardiomyocytes. There is also some evidence that
implicates the CaMKII pathway in Ca2+ dysregulation in
OVX hearts. Levels of CaMKIIδ and phosphorylated CaM-
KII protein are higher in ventricular tissue from OVX com-
pared to sham controls [70]. This could augment SR Ca2+
release, as CaMKII-dependent phosphorylation of RyR2 is
known to increase the amplitude and duration of Ca2+
sparks [50]. Together, these observations suggest that en-
hanced phosphorylation of various components of the EC
coupling pathway may augment SR Ca2+ release and ulti-
mately cause intracellular Ca2+ dysregulation following sex
hormone withdrawal in females. Further studies that focus
on sex hormone modulation of signalling pathways that
regulate EC coupling could be highly informative.
Even though the ovaries are the primary source of oes-
trogens, gonadally derived steroid hormones are not the
only source of systemic oestrogens in female animals. Other
cell types including bone and adipocytes express the en-
zyme aromatase, which can convert testosterone to 17ß-
758 Pflugers Arch - Eur J Physiol (2013) 465:747–763
estradiol [101]. Aromatase is expressed in both neonatal
tissues and cardiomyocytes [48, 85], as well as in the adult
rodent heart [2]. This raises the interesting possibility that
androgens can be locally converted to oestrogens in the
myocardium [2]. Whether exposure of cardiomyocytes to
sex steroid hormones can be regulated at the local tissue
level is an important area for further investigation.
Acute and chronic effects of male sex hormones on EC
coupling
Previous studies have shown that functional androgen
receptors are present on cardiomyocytes [47, 72]. Therefore,
some studies have investigated the effects of both acute and
chronic application of testosterone on cardiomyocyte func-
tion. Er et al. [36] found that acute application of supra-
physiological concentrations of dihydrotestosterone
(100 nM) to ventricular myocytes from female rats caused
a marked reduction in the magnitude of the Ca2+ current.
Interestingly, these authors also showed that treatment with
similar amounts of dihydrotestosterone for 24 h had the
opposite effect and enhanced Ca2+ current [36]. This in-
crease in Ca2+ current density was associated with an in-
crease in expression of the α1C subunit of the Ca2+ channel
[36]. Acute treatment with 100 nM dihydrotestosterone had
no effect on Ca2+ spark frequency or amplitude, but 24 h
treatment increased the frequency of SR Ca2+ sparks, with-
out affecting their amplitude [36]. Interestingly, 24 h of
exposure to 100 nM dihydrotestosterone had no effect on
SR Ca2+ stores in cardiomyocytes [36, 44]. By contrast, 24 h
of treatment with dihydrotestosterone caused an increase in
both Ca2+ transient amplitudes and fractional shortening
[36, 44]. These results suggest that both acute and chronic
exposure to high concentrations of testosterone affect intra-
cellular Ca2+ handling. While acute exposure may limit Ca2+
entry, chronic (up to 24 h) exposure increases Ca2+ influx and
augments both SR Ca2+ release and contraction. However,
physiological levels of testosterone are in the range of 10–
35 nM in adult men [30] and fluctuate around a similar range
in rodent models [75]. Additional studies that use more phys-
iological concentrations of testosterone and longer exposure
times could be informative.
Very few studies have evaluated the impact of long-term
male gonadal steroid hormone withdrawal on cardiac contrac-
tile function. Golden et al. [43] used gonadectomisedmale rats
to examine the effect of testosteronewithdrawal on cardiac EC
coupling. They showed that, 16 weeks after gonadectomy,
isolated cardiomyocytes exhibited a significantly slower rate
of shortening and relaxation in comparison to sham controls,
although there was no difference in peak contraction [43].
When rats were subjected to sex hormone replacement, these
differences between sham and gonadectomised animals were
abolished [43]. Other studies have examined cardiac muscle
strips and isolated myocytes from rats 2 weeks after gonadec-
tomy and reported a decrease in both peak contraction and
peak Ca2+ transient amplitudes, as well as slower decay of
both responses when compared to controls [26, 120]. Impor-
tantly, these changes were reversed after testosterone replace-
ment [26]. These findings indicate that removal of male
gonadal steroid hormones inhibits SR Ca2+ release and sug-
gest that testosterone may augment SR Ca2+ release. This
agrees with the results of previous studies, described above,
where testosterone was acutely applied to cardiomyocytes for
24 h. Future studies should investigate the specific compo-
nents of EC coupling that are affected by testosterone and
identify the intracellular signalling pathways that may be
implicated in these effects.
Summary
The past decade has seen advances in our understanding of
the impact of sex on cardiac contractile function, although
much remains to be investigated. There is growing evidence
that peak contractions are smaller and slower in intact hearts
and cardiac muscle preparations from females when com-
pared to males. This is due, in large part, to a decrease in the
ability of individual cardiomyocytes to contract. Sex differ-
ences at several different locations in the EC coupling
pathway have been implicated (Fig. 2). Most notably, new
studies have shown that cardiomyocytes from female hearts
exhibit a marked decrease in the gain of EC coupling, which
translates to a decrease in SR Ca2+ release. This has been
observed as lower peak Ca2+ transients and smaller individ-
ual SR Ca2+ sparks in myocytes from females, in compari-
son to males. Nonetheless, little is known about the specific
signalling pathways implicated in these sex differences, and
this limits the ability to translate these findings to new
therapeutic strategies.
Although information is limited, sex differences in cardi-
ac contractile function may be linked to effects of the major
sex hormones on components of the EC coupling pathway.
There is some evidence that acute application of high con-
centrations of 17β-estradiol, progesterone or testosterone
can modify EC coupling mechanisms. However, whether
more physiological concentrations of these hormones have
similar effects is not yet clear. There is evidence from
studies in ovariectomized rodents that chronic reduction in
circulating 17β-estradiol modifies EC coupling mecha-
nisms. Importantly, OVX causes a marked increase in the
gain of EC coupling, resulting in larger peak Ca2+ transients
and larger Ca2+ sparks. These results strongly suggest that
oestrogen suppresses SR Ca2+ release and contributes
importantly to the reduction in EC coupling gain present
in cardiomyocytes from females. OVX also promotes car-
diomyocyte Ca2+ dysregulation, including elevated SR Ca2+
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content and larger unitary Ca2+ release events. This SR Ca2+
overload promotes the spontaneous release of Ca2+ from the
SR. This could increase susceptibility to a range of different
cardiovascular diseases in low oestrogen states, such as in
older, post-menopausal women. New research that explores
the intracellular signalling pathways involved in these
effects could lead to the identification of new targets for
the treatment of cardiovascular diseases in older women.
There is a growing literature that suggests that oestrogen
contributes to sex differences in myocardial contractile func-
tion, although this work is far from complete. Even less
attention has been paid to the effects of testosterone on
cardiac contraction, either at the intact heart level or at the
cellular level. Intriguing evidence suggests that chronic re-
duction in circulating testosterone levels reduces the con-
tractility of individual cardiomyocytes and suppresses Ca2+
transients. This raises the possibility that testosterone may
increase intracellular Ca2+ levels through effects on EC
coupling mechanisms, although this has not yet been inves-
tigated. If the loss of testosterone reduces intracellular Ca2+
levels in older men, this could suppress contractile function
and contribute to systolic dysfunction in this population.
These findings that implicate sex hormone-regulated sig-
nalling pathways in the modulation of cardiac contractile
function are potentially very important. If sex hormones
such as oestrogen and testosterone are primary determinants
of EC coupling gain, understanding the signalling pathways
that regulate these actions can shed light on unique factors
responsible for differences in cardiovascular disease expres-
sion in older men and women. This could lead to the
identification of potential targets for the development of
new agents to treat diseases such as cardiac contractile
dysfunction and systolic heart failure in both men and
women.
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